FDA scientists opposed Trump administration’s move to ease peptide access

FDA scientific staff members opposed a plan to ease access to unproven peptide drugs, favored by Health Secretary Robert F Kennedy Jr. The Department of Health and Human Services posted the policy online on Wednesday.